Macrophage inhibitory cytokine-1 (MIC-1/GDF15): A new marker of all-cause mortality

Aging Cell

Volumn 9, Issue 6, 2010, Pages 1057-1064

  Wiklund, Fredrik E ^a   Bennet, Anna M ^a   Magnusson, Patrik K E ^a   Eriksson, Ulrika K ^a   Lindmark, Fredrik ^b   Wu, Liyun ^c   Yaghoutyfam, Nasreen ^c   Marquis, Christopher P ^c   Stattin, Pär ^b   Pedersen, Nancy L ^a   Adami, Hans Olov ^a,d   Grönberg, Henrik ^a   Breit, Samuel N ^c   Brown, David A ^c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

All cause mortality; Cytokine; Environmental toxicity; MIC 1 GDF15; Prospective observational cohort; Serum marker

Indexed keywords

BIOCHEMICAL MARKER; C REACTIVE PROTEIN; GROWTH DIFFERENTIATION FACTOR 15; INTERLEUKIN 6;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CORRELATION ANALYSIS; FEMALE; HERITABILITY; HUMAN; MALE; MORTALITY; PRIORITY JOURNAL; SURVIVAL TIME; TELOMERE;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; COHORT STUDIES; FEMALE; GROWTH DIFFERENTIATION FACTOR 15; HUMANS; INTERLEUKIN-6; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MORTALITY; NEOPLASMS; REGISTRIES; SWEDEN;

EID: 78249249270     PISSN: 14749718     EISSN: 14749726     Source Type: Journal    
DOI: 10.1111/j.1474-9726.2010.00629.x     Document Type: Article

References (39)

1. Bakaysa SL, Mucci LA, Slagboom PE, Boomsma DI, McClearn GE, Johansson B, Pedersen NL (2007) Telomere length predicts survival independent of genetic influences. Aging Cell 6, 769-774.
2. Bauskin AR, Brown DA, Junankar S, Rasiah KK, Eggleton S, Hunter M et al. (2005) The propeptide mediates formation of stromal stores of promic-1: role in determining prostate cancer outcome. Cancer Res. 65, 2330-2336.
3. Bauskin AR, Brown DA, Kuffner T, Johnen H, Luo XW, Hunter M et al. (2006) Role of macrophage inhibitory cytokine-1 in tumorigenesis and diagnosis of cancer. Cancer Res. 66, 4983-4986.
4. Bianchi G, Di Giulio C, Rapino C, Rapino M, Antonucci A, Cataldi A (2006) P53 and p66 proteins compete for hypoxia-inducible factor 1 alpha stabilization in young and old rat hearts exposed to intermittent hypoxia. Gerontology 52, 17-23.
5. Bonafe M, Barbieri M, Marchegiani F, Olivieri F, Ragno E, Giampieri C et al. (2003) Polymorphic variants of insulin-like growth factor I (igf-I) receptor and phosphoinositide 3-kinase genes affect igf-I plasma levels and human longevity: cues for an evolutionarily conserved mechanism of life span control. J. Clin. Endocrinol. Metab. 88, 3299-3304.
6. Brown DA, Bauskin AR, Fairlie WD, Smith MD, Liu T, Xu N et al. (2002a) Antibody-based approach to high-volume genotyping for mic-1 polymorphism. BioTechniques 33, 118-120, 122, 124 passim.
7. Brown DA, Breit SN, Buring J, Fairlie WD, Bauskin AR, Liu T et al. (2002b) Concentration in plasma of macrophage inhibitory cytokine-1 and risk of cardiovascular events in women: a nested case-control study. Lancet 359, 2159-2163.
8. Brown DA, Stephan C, Ward RL, Law M, Hunter M, Bauskin AR et al. (2006) Measurement of serum levels of macrophage inhibitory cytokine 1 combined with prostate-specific antigen improves prostate cancer diagnosis. Clin. Cancer Res. 12, 89-96.
9. Brown DA, Moore J, Johnen H, Smeets TJ, Bauskin AR, Kuffner T et al. (2007) Serum macrophage inhibitory cytokine 1 in rheumatoid arthritis: a potential marker of erosive joint destruction. Arthritis Rheum. 56, 753-764.
10. Carrero JJ, Stenvinkel P, Fellstrom B, Qureshi AR, Lamb K, Heimburger O et al. (2008) Telomere attrition is associated with inflammation, low fetuin-a levels and high mortality in prevalent haemodialysis patients. J. Intern. Med. 263, 302-312.
11. Chin L, Artandi SE, Shen Q, Tam A, Lee SL, Gottlieb GJ et al. (1999) P53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell 97, 527-538.
12. Donehower LA (2009) Using mice to examine p53 functions in cancer, aging, and longevity. Cold Spring Harb. Perspect. Biol. 1, a001081.
13. Dostalova I, Kavalkova P, Papezova H, Domluvilova D, Zikan V, Haluzik M (2010) Association of macrophage inhibitory cytokine-1 with nutritional status, body composition and bone mineral density in patients with anorexia nervosa: the influence of partial realimentation. Nutr. Metab. (Lond.) 7, 34.
14. Efron B (1979) Bootstrap methods: another look at the jackknife. Ann. Stat. 7, 1-26.
15. Fontana L, Partridge L, Longo VD (2010) Extending healthy life span - from yeast to humans. Science 328, 321-326.
16. Hanley JA, McNeil BJ (1983) A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 148, 839-843.
17. Harrill JA, Li Z, Wright FA, Radio NM, Mundy WR, Tornero-Velez R et al. (2008) Transcriptional response of rat frontal cortex following acute in vivo exposure to the pyrethroid insecticides permethrin and deltamethrin. BMC Genomics 9, 546.
18. Horwich TB, Fonarow GC (2007) Reverse epidemiology beyond dialysis patients: chronic heart failure, geriatrics, rheumatoid arthritis, copd, and aids. Semin. Dial. 20, 549-553.
19. Johnen H, Lin S, Kuffner T, Brown DA, Tsai VW, Bauskin AR et al. (2007) Tumor-induced anorexia and weight loss are mediated by the tgf-beta superfamily cytokine mic-1. Nat. Med. 13, 1333-1340.
20. Kempf T, Bjorklund E, Olofsson S, Lindahl B, Allhoff T, Peter T et al. (2007) Growth-differentiation factor-15 improves risk stratification in st-segment elevation myocardial infarction. Eur. Heart J. 28, 2858-2865.
21. Lankeit M, Kempf T, Dellas C, Cuny M, Tapken H, Peter T et al. (2008) Growth-differentiation factor-15 for prognostic assessment of patients with acute pulmonary embolism. Am. J. Respir. Crit. Care Med. 177, 1018-1025.
22. Lichtenstein P, De Faire U, Floderus B, Svartengren M, Svedberg P, Pedersen NL (2002) The swedish twin registry: a unique resource for clinical, epidemiological and genetic studies. J. Intern. Med. 252, 184-205.
23. Lim DS, Vogel H, Willerford DM, Sands AT, Platt KA, Hasty P (2000) Analysis of ku80-mutant mice and cells with deficient levels of p53. Mol. Cell. Biol. 20, 3772-3780.
24. Lindmark F, Zheng SL, Wiklund F, Bensen J, Balter KA, Chang B et al. (2004) H6D polymorphism in macrophage-inhibitory cytokine-1 gene associated with prostate cancer. J. Natl Cancer Inst. 96, 1248-1254.
25. McClearn GE, Johansson B, Berg S, Pedersen NL, Ahern F, Petrill SA et al. (1997) Substantial genetic influence on cognitive abilities in twins 80 or more years old. Science 276, 1560-1563.
26. Neale MC, Boker SM, Xie G, Maes H (2006) Mx: Statistical Modeling (7 edn). VCU Box 900126, Richmond, VA 23298: Department of Psychiatry.
27. Nielsen C, Lippke H, Didier A, Dietrich R, Martlbauer E (2009) Potential of deoxynivalenol to induce transcription factors in human hepatoma cells. Mol. Nutr. Food Res. 53, 479-491.
28. Pang RP, Zhou JG, Zeng ZR, Li XY, Chen W, Chen MH et al. (2007) Celecoxib induces apoptosis in cox-2 deficient human gastric cancer cells through akt/gsk3beta/nag-1 pathway. Cancer Lett. 251, 268-277.
29. Rudolph KL, Chang S, Lee HW, Blasco M, Gottlieb GJ, Greider C et al. (1999) Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell 96, 701-712.
30. Saletta F, Rahmanto YS, Noulsri E, Richardson DR (2010) Iron chelator-mediated alterations in gene expression: identification of novel iron-regulated molecules that are molecular targets of hypoxia-inducible factor-1 alpha and p53. Mol. Pharmacol. 77, 443-458.
31. Salmon AB, Richardson A, Perez VI (2010) Update on the oxidative stress theory of aging: does oxidative stress play a role in aging or healthy aging? Free Radic. Biol. Med. 48, 642-655.
32. Simm A, Nass N, Bartling B, Hofmann B, Silber RE, Navarrete Santos A (2008) Potential biomarkers of ageing. Biol. Chem. 389, 257-265.
33. Subramaniam S, Strelau J, Unsicker K (2003) Growth differentiation factor-15 prevents low potassium-induced cell death of cerebellar granule neurons by differential regulation of akt and erk pathways. J. Biol. Chem. 278, 8904-8912.
34. Suh Y, Atzmon G, Cho MO, Hwang D, Liu B, Leahy DJ et al. (2008) Functionally significant insulin-like growth factor I receptor mutations in centenarians. Proc. Natl. Acad. Sci. U S A 105, 3438-3442.
35. Team DC (2006). A Language and Environment for Statistical Computing.Vienna (Austria): Foundation for Statistical Computing.
36. Tyner SD, Venkatachalam S, Choi J, Jones S, Ghebranious N, Igelmann H et al. (2002) P53 mutant mice that display early ageing-associated phenotypes. Nature 415, 45-53.
37. Welsh JB, Sapinoso LM, Kern SG, Brown DA, Liu T, Bauskin AR et al. (2003) Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum. Proc. Natl. Acad. Sci. U S A 100, 3410-3415.
38. Wollmann W, Goodman ML, Bhat-Nakshatri P, Kishimoto H, Goulet RJJ, Mehrotra S et al. (2005) The macrophage inhibitory cytokine integrates akt/pkb and map kinase signaling pathways in breast cancer cells. Carcinogenesis 26, 900-907.
39. Yamaguchi K, Lee SH, Eling TE, Baek SJ (2004) Identification of nonsteroidal anti-inflammatory drug-activated gene (nag-1) as a novel downstream target of phosphatidylinositol 3-kinase/akt/gsk-3beta pathway. J. Biol. Chem. 279, 49617-49623.